MedTrace Logo

Control of Blood Loss During Caesarean Section

NCT01412073 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2014-10-07

No results posted yet for this study

Summary

trial of 3 protocols to determine the best one to control blood loss during caesarean section

Conditions

  • Complications; Cesarean Section

Interventions

DRUG

oxytocin

group I : oxytocin 5 IU bolus over 3 minutes after delivery of the baby group II : oxytocin 5 IU bolus over 3 minutes after delivery of the baby and oxytocin infusion in 500 ml 0.9% saline over 4 hours

DRUG

Misoprostol

misoprostol intrauterine 800 microgram placed intrauterine after delivery of the baby \& the placenta

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Waleed M El-khayat, M.D. · Lecturer of Obstetrics & Gynecology , Faculty of medicine, Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2014-09-30
Completion
2014-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01412073 on ClinicalTrials.gov